Zobrazeno 1 - 10 of 18 pro vyhledávání: '"J M, Viteau"'
1
Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis
Autor: R Van Heuverzwijn, E Froguel, J M Viteau, A Galian, Marc Lémann, Antoine Cortot, Robert Modigliani, Jacques Belaiche, Paul Rutgeerts, A Elewaut
Publikováno v: Alimentary pharmacologytherapeutics. 9(5)
SUMMARY Background: Budesonide is a new corticosteroid with high topical anti-inflammatory activity but little systemic effect. The aim of the present study was to compare the efficacy and safety of budesonide enema (2 mg/100 mL) and 5-ASA enema (mes
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0773ad3bc97d9e400071e42ff1d9c0d3
https://pubmed.ncbi.nlm.nih.gov/8580278
Zobrazit plný text záznamu
2
[Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders]
Autor: J P, Gendre, J Y, Mary, C, Florent, R, Modigliani, J F, Colombel, J C, Soulé, J P, Galmiche, E, Lerebours, L, Descos, J M, Viteau
Publikováno v: Annales de gastroenterologie et d'hepatologie. 29(5)
Mesalamine provides a new therapeutic approach in treating Crohn's disease.To assess the efficacy and safety of slow-release mesalamine (Pentasa) in maintaining remission in Crohn's disease, 161 patients with inactive disease were randomized to recei
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::eb5edb039b36c99bade318cb335bcbe7
https://pubmed.ncbi.nlm.nih.gov/8250520
Zobrazit plný text záznamu
3
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)
Autor: J P, Gendre, J Y, Mary, C, Florent, R, Modigliani, J F, Colombel, J C, Soulé, J P, Galmiche, E, Lerebours, L, Descos, J M, Viteau
Publikováno v: Gastroenterology. 104(2)
Mesalamine provides a new therapeutic approach in treating Crohn's disease.To assess the efficacy and safety of slow-release mesalamine (Pentasa; Ferring AS, Vanløse, Denmark) in maintaining remission in Crohn's disease, 161 patients with inactive d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::83b2cf62a9552d7a8b8f1c3875323731
https://pubmed.ncbi.nlm.nih.gov/8299923
Zobrazit plný text záznamu
4
Rioprostil and Ranitidine in the Prevention of Duodenal Ulcer Relapse
Autor: J L Slama, B Veyres, J M Viteau, A Lavignolle, A Raillat, M Vray, P Rampal, F Prunieras, J Toulet, L Bedenne
Publikováno v: Scandinavian Journal of Gastroenterology. 24:146-151
One hundred and ninety duodenal ulcer patients who had relief of pain and endoscopically proven ulcer healing after a short treatment period are allocated at random to double-blind maintenance treatment with a synthetic dehydroprostaglandin-E1, riopr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dfc3fee2f8ae1451a8a6dcf10b603fe
https://doi.org/10.3109/00365528909091204
Zobrazit plný text záznamu
5
Rioprostil vs. Ranitidine in Duodenal Ulcer Healing: A Double-Blind Multicentre Trial
Autor: A. Lavignolle, A. Raillat, J. L. Slama, J. M. Viteau, B. Veyres, P. Lebourgeois, J. C. Audigier, J. Abgrall, H. Parlier, M. Vray, P. Dupuy, L. Le Bodic, T. Toulet, F. Prunieras, P. Rampal
Publikováno v: Scandinavian Journal of Gastroenterology. 24:194-197
A total of 156 patients with endoscopically proven duodenal ulcers are randomized in a double-blind, multicentre trial comparing rioprostil, 300 micrograms b.d., with ranitidine, 150 mg b.d. With rioprostil, the cumulative healing rate by endoscopy i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::259ecc71078b37f611e446a48e1a1372
https://doi.org/10.3109/00365528909091212
Zobrazit plný text záznamu
7
[Inhibition by a 2-pyridyltetrahydrothiophene derivative (40749 RP) of gastric secretion stimulated by pentagastrin. Results in 30 duodenal ulcer patients]
Autor: J, Toulet, R, Pagniez, J M, Viteau, F, Bosc, J L, Vienne
Publikováno v: Gastroenterologie clinique et biologique. 8(2)
The aim of this study was to investigate the effects of a new antisecretory compound (40749 RP) on the pentagastrin stimulated gastric secretion (6 micrograms.kg-1 b. w. h-1) in 30 patients with duodenal ulcer. The drug was administered directly into
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::16190cad6586a73f84d83b8acedcab86
https://pubmed.ncbi.nlm.nih.gov/6698354
Zobrazit plný text záznamu
8
[Ranitidine inhibition of gastric secretion stimulated by pentagastrin. Results in 30 cases of duodenal ulcer]
Autor: J, Toulet, R, Pagniez, J M, Viteau, J, Rousselet, F, Bosc, J L, Vienne
Publikováno v: Annales de gastroenterologie et d'hepatologie. 22(1)
The aim of this study was to investigate the effects of ranitidine on the pentagastrin stimulated gastric secretion (6 micrograms.kg.h) in 30 patients with duodenal ulcer. The drug was administered directly into the gastric lumen. Five different dose
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e210da29afd9651fc01680ec476ca0c1
https://pubmed.ncbi.nlm.nih.gov/3083759
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje